NCT00050622
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
See it on ClinicalTrials.gov ↗154 people
15.6%
84.4%
24 womenmiddle line = equal numbers130 men
- Phase
- NA
- Paid for by
- Florida International University
- Finished
- 2005-06
- Health conditions
- Attention Deficit Disorder With Hyperactivity
- Who could join
- Anyone
- Ages
- 5 Years – 12 Years
- Average age
- mean 9.15 Years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 79.2% · Black / African American 12.3% · More than one race 5.8% · Asian 1.3% · American Indian / Alaska Native 0.6% · Not reported 0.6% · Native Hawaiian / Pacific Islander 0%
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 12 Years.”
- No seizures
Women with epilepsy or past seizures were turned away.
“History of seizures or other neurological problems”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“History or concurrent diagnosis of any of the following disorders: pervasive developmental disorder, schizophrenia or other psychotic disorders, sexual disorder, organic mental disorder, or eating disorder”
Study titles and rules are shown in their original English.